Last Updated: July 8, 2026

DURAMORPH Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Duramorph patents expire, and when can generic versions of Duramorph launch?

Duramorph is a drug marketed by Hikma and is included in one NDA.

The generic ingredient in DURAMORPH is morphine sulfate. There are twenty-three drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Duramorph

A generic version of DURAMORPH was approved as morphine sulfate by HOSPIRA on September 30th, 1992.

  Start Trial

AI Deep Research
Questions you can ask:
  • What is the 5 year forecast for DURAMORPH?
  • What are the global sales for DURAMORPH?
  • What is Average Wholesale Price for DURAMORPH?
Summary for DURAMORPH
US Patents:0
Applicants:1
NDAs:1
Drug Prices: Drug price information for DURAMORPH
What excipients (inactive ingredients) are in DURAMORPH?DURAMORPH excipients list
DailyMed Link:DURAMORPH at DailyMed

US Patents and Regulatory Information for DURAMORPH

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hikma DURAMORPH PF morphine sulfate INJECTABLE;INJECTION 018565-001 Sep 18, 1984 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Hikma DURAMORPH PF morphine sulfate INJECTABLE;INJECTION 018565-002 Sep 18, 1984 AP RX Yes Yes ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.